Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AC Alternatives® Equity Market Neutral Fund R Class (ALIRX)

Net Asset Value
1 Day
Overall Morningstar Rating
Market neutral
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation independent of equity market conditions. In selecting stocks for the fund, the portfolio managers use quantitative management techniques in a two-step process. First, the managers rank stocks, primarily publicly traded U.S. companies with a market capitalization greater than $1 billion. Second, the portfolio managers use a quantitative model to build a portfolio of stocks from the ranking that they believe will provide the optimal balance between risk and expected return. The fund will invest at least 80% of its net assets in equity investments.


1 month-0.56% 3 years-0.65%
3 months+0.47% 5 years+0.83%
1 year+1.04% Since inception+0.74%
Data through --

Peer Comparisonvs. Market neutral

Performance 5-yr return+0.83%+0.88%
Expense ratio3.43%1.63%
Risk 5 year sharpe ratio0.230.26
Net assets$114.7M$409.5M
Average market cap$7.4B$32.9B
Average P/E20.021.1
Portfolio turnover344%344%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAmerican Century Investments
Fund manager & tenureClaudia Musat / 11 Years
Minimal initial investment$2,500.00
Minimum IRA investment--


International stock0.50%
U.S. stock0.00%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Financial service 13.64%
Industrial materials 12.37%
Consumer goods 12.06%
Energy 10.52%
Hardware 10.46%
Top 10 Holdings
Portfolio weighting
PODD Insulet Corp0.75%
BLL Ball Corp0.75%
BYD Boyd Gaming Corp0.74%
TDC Teradata Corp0.72%
APD Air Products and Chemicals Inc0.71%
CLH Clean Harbors Inc0.70%
NUS NU Skin Enterprises Inc0.70%
UMBF UMB Financial Corp0.70%
ABT Abbott Laboratories0.70%
SATS EchoStar Corp0.69%